A survey of strategic licensing practices in the pharmaceutical industry Alliances often appear to be a relatively cost-effective and rapid […]
A survey of strategic licensing practices in the pharmaceutical industry Read Post »
The Generic Retribution The generic industry has always been overshadowed by branded pharmaceuticals. The government policies and the mandate have
October sees a frenzy of biotech IPOs October was the busiest month in three years for initial public offerings in
Venture Financing: Ready To Rebound? There’s little doubt that the financing window has opened up, but investors, analysts and biotech
Analyzing Brand-name and Generic Drug Costs in the U.S. and Eight Other Countries A new Wharton study comparing average prices
Analyzing Brand-name and Generic Drug Costs in the U.S. and Eight Other Countries Read Post »
Gene Tests? Not So Fast The U.S. Food and Drug Administration Monday released draft guidelines regarding how genetic data could
States flock to biotech like gamblers to lottery tickets Florida lawmakers last month approved a $310 million biotech research center
States flock to biotech like gamblers to lottery tickets Read Post »
In Initial Finding, FDA Calls Cloned Animals Safe as Food Milk and meat from cloned animals are safe to consume,
In Initial Finding, FDA Calls Cloned Animals Safe as Food Read Post »
Biotech Startups: Take Your Time Until startups’ products are close to gaining approval, there’s no reason why smart investors would
Has the debate on GM crops been misleading? More than a hundred scientists have written to Tony Blair, complaining about